Alcon Inc & Novartis AG | Update Date: 07/13/08 |
| Date Announced: 04/07/08 |
| Value (million $USD): 10.55 billion U.S. Dollar |
|
| Status: Completed | |
| TRANSACTION DETAILS |
| Date Announced | 04/07/08 | | |
| Date Originally Announced | 04/07/08 | | |
| Format | Acq. Part. Int. | Acquisition techniques | Privately Negotiated Purc |
| Attitude | Friendly | Agency | Unspecified Regulatory Auth. |
| Value | 10.55 billion U.S. Dollar | Advisor Fees | n/a |
| SYNOPSIS |
| US - Novartis AG (NA) acquired a 25% stake, or 73.666 mil common shares, in Alcon Inc (AI), a manufacturer and wholesaler of pharmaceuticals, surgical equipment and devices, and contact lens care and other vision care products, from Nestle SA, for $143.18 in cash per share, or a total value of $10.547 bil, in a privately negotiated transaction. The transaction had been subject to regulatory approval. Concurrently, NA was granted an option to raise its interest to 77% from 25% by acquiring a 52% interest, or 153.225 mil common shares, in AI. |
| TARGET |
| Name | Alcon Inc (ACL) |
| Industries | Surgical and medical instruments and apparatus; Pharmaceutical preparations; Medical, dental, and hospital equipment & supplies |
| City | Fort Worth |
| State | TX |
| Nation | United States |
| Incorporated in | n/a |
| Public Status | Public |
| Business Description | Alcon Inc, located in Fort Worth, Texas, manufactures and wholesales pharmaceuticals, surgical equipment and devices, and contact lens care and other vision care products that treat conditions of the eye. The company was founded in 1945. |
| Advisors | Credit Suisse Group; Citi |
| Target Sales | 5.94 billion U.S. Dollar |
|
| ACQUIROR |
| Name | Novartis AG (Zurich : NOVZN) |
| Industries | Ophthalmic goods; Dry, condensed, and evaporated dairy products; Canned specialties; Offices of holding companies, nec |
| City | Basel |
| State | n/a |
| Nation | Switzerland |
| Incorporated in | n/a |
| Public Status | Public |
| Business Description | Novartis AG, headquartered in Basel, Switzerland, manufactures pharmaceuticals including self-medications and non-prescription drugs. It also manufactures optical and ophthalmic products including contact lenses. The company produces nutritional products including baby formula and baby canned food and serves as a holding company. It was founded in 1996. |
| Advisors | Goldman Sachs & Co |
| Acquiror Sales | 44.74 billion U.S. Dollar 44.49 billion Swiss Franc |
|

|
|